In the News
EvergreenHealth was awarded a $10,000 grant from the Michael J. Fox Foundation (MJFF) for Parkinson's Research
Read about the grant >
FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea
August 2019
https://www.prnewswire.com/news-releases/fda-approves-us-worldmeds-myobloc-rimabotulinumtoxinb-injection-for-chronic-sialorrhea-300906932.html
Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies
August 2019
https://www.novartis.com/news/media-releases/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-two-head-head-phase-iii-multiple-sclerosis-studies
APDA Research Symposium
April 2019
EvergreenHealth Neurologist and Parkinson's expert Dr. Pinky Agarwal participated in the researcher panel: